AATOD Announces NEW Guidelines for Involuntary Withdrawal from Methadone Maintenance Treatment Due to Non-Payment of Fees
July 21, 2003, New York
You can download the files in a zipfile. You will need a decompression application and a graphic viewer to access the files. The files are jpg files. Note: Windows XP has a built in decompression application and all windows versions have a graphic viewer.
Dr Andrew Byrne, Medical Practitioner, Drug and Alcohol New South Wales, Australia Email – [email protected] September 23, 2003 This study randomised consenting heroin dependent subjects to receive one month’s treatment with (i) buprenorphine, (ii) buprenorphine/naloxone or (iii) placebo. For a further 11 months, surviving (sic) patients were followed in an open-label manner for primary outcome…
These documents communicate the aspects of what quality methadone maintenance treatment should be. This is not a complete list of the Policy Statements that NAMA has issued. Some important research by addiction treatment experts has been added. Methadone Medical Maintenance Policy Statement 1 April 1994 The Policy of Blind Dosing and Patient Dignity Policy Statement…
T01-15 April 20, 2001 Print Media: 301-827-6242 Broadcast Media: 301-827-3434 Consumer Inquiries: 888-INFO-FDA FDA Warns About Orlaam The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With Addiction…
COVID-19 Resources Get Federal, State, Organization and other information. more info Find Treatment Search our national database of treatment an other related resources. more info NAMA Library Get Federal, State, Organization and other information. more info We offer information about your rights under HIPPA and answers to frequently asked questions about the HIPPA rules. HIPPA…
FOR IMMEDIATE RELEASE: October 9, 2002 NIDA Contact: Michelle Person 301-443-6245 SAMHSA Contact: Leah Young 301-443-8956 NIDA Research and SAMHSA Physician Training Combine to Put Care for Opiate Dependence in Hands of Family Doctor. Buprenorphine, a new medication developed through more than a decade of research supported by the National Institute on Drug Abuse (NIDA),…
Education Series Number 9 January 1999 Letter Supplement O N Y O U R L E T T E R H E A D Dear Doctor: The bearer of this letter is a patient in a methadone maintenance treatment program. Methadone patients frequently need treatment for other medical, surgical, and dental conditions. At times the health professional…
